In 1978, Cooper and associates first described resecting
|
|
- Emil Carroll
- 5 years ago
- Views:
Transcription
1 Median Sternotomy Versus Thoracotomy to Resect Primary Lung Cancer: Analysis of 815 Cases James W. Asaph, MD, John R. Handy, Jr, MD, Gary L. Grunkemeier, PhD, E. Charles Douville, MD, Andrew C. Tsen, MD, Richard C. Rogers, MD, and John F. Keppel, MD The Oregon Clinic, P.C., Earle A. Chiles Research Institute, and Medical Data Research Center, Providence Health System, Portland, Oregon Background. We sought to determine if median sternotomy (MS) is an equivalent incision to thoracotomy (TH) in the treatment of primary pulmonary carcinoma. Methods. We followed 801 patients undergoing 815 operations for primary lung carcinoma in a computer registry; 447 had MS, 368 had TH. Results. Both groups were similar in preoperative risk assessment. Complete staging lymph node dissections were performed in 42% of MS patients and 17% of TH patients. Operative mortality (3.8% for MS, 3.3% for TH) and postoperative complications were similar. MS patients had a shorter postoperative hospital stay (7.5 days vs 8.2 days). One hundred thirty-nine underwent pneumonectomy. Operative mortality was 12.5% for MS and 10.4% for TS (p NS). Five hundred eighty-one underwent lobectomy with an operative mortality of 2.1% for MS and 2.0% for TH. Mean length of stay for MS lobectomy was 7.5 days compared with 8.5 days for TH (p 0.06). Follow-up was 89% through 1998, comprising 1,339 MS and 1,463 TH patient-years. Survival for stage I at 5 and 10 years, respectively, was 51% and 34% for MS vs 54% and 32% for TH (p NS). Survival for other stages was also similar. Conclusions. Median sternotomy provides more complete staging, shorter postoperative hospitalization, and better patient acceptance with equivalent operative and long-term survival when compared with thoracotomy. Concerns regarding increased wound infections in MS patients appear unfounded. (Ann Thorac Surg 2000;70:373 9) 2000 by The Society of Thoracic Surgeons In 1978, Cooper and associates first described resecting primary pulmonary cancer through a median sternotomy (MS) [1]. In 1980, Urschel and Razzuk presented their experience with MS for resecting primary lung tumors at The Society of Thoracic Surgeons meeting [2]. Both recognized that cardiac surgery through MS appears to cause less incisional pain and fewer pulmonary complications compared with thoracotomy (TH). However, concerns about completeness of resection, hilar control, and the disastrous complication of deep sternal wound infections [3] have kept MS from becoming widespread as an approach for resection of lung cancer. We began using MS for resection of primary pulmonary carcinoma in Early in our experience, we compared the use of postoperative analgesics between MS and TH groups [4]. The MS patients used significantly fewer analgesics than patients undergoing TH. Subsequently, we have preferentially utilized MS for resection of lung neoplasms. Currently, MS is utilized in approximately 75% of our pulmonary resections (Fig 1). This report compares MS with TH as the primary incision for surgical treatment of primary lung carcinoma Accepted for publication Feb 18, Address reprint requests to Dr Handy, The Oregon Clinic, P.C., 507 NE 47th Ave, Portland, OR in terms of adequacy of resection, length of stay, operative morbidity and mortality, and long-term survival in 815 pulmonary operations. Material and Methods A computerized registry (Patient Analysis & Tracking System; Axis Softwear, Portland, OR) was used to track 2,324 consecutive patients undergoing thoracic surgery procedures by a single group of thoracic surgeons operating in two medical centers from January 1980 through December Patients undergoing surgery before 1984 were entered retrospectively by chart review. Since then, all patients were entered prospectively at the time of, or shortly after, their surgery. Only patients undergoing planned pulmonary resection for primary lung carcinoma were selected for analysis. Video-assisted thoracotomies for biopsy or local excisions were excluded. Longterm follow-up was tracked from hospital tumor registries and managed care systems data sources. Data collected included patient demographics, preoperative risk factors, diagnostic procedures, operative features, pathology, stage, postoperative complications, and mortality. Stage was determined according to the Manual for Staging of Cancer, 4th Edition [5]. Follow-up information included date of last follow-up, administration of radiation or chemotherapy, current tumor status, and 2000 by The Society of Thoracic Surgeons /00/$20.00 Published by Elsevier Science Inc PII S (00)
2 374 ASAPH ET AL Ann Thorac Surg MEDIAN STERNOTOMY TO RESECT LUNG CANCER 2000;70:373 9 cause of death. Statistical calculations were performed with SPSS 9.0 (SPSS, Inc, Chicago, IL) and PATS (Axis Software, Portland, OR). Values greater than p 0.05 are designated NS. Postoperative length of stay (LOS) was compared by unpaired t test. Survival was calculated by the Kaplan-Meier technique. MS was performed utilizing standard techniques with the arms tucked by the sides. All patients had radial artery monitoring lines and double lumen endobronchial intubation. Mediastinoscopy was performed selectively; however, since 1991, complete mediastinal staging lymph node dissection has been performed routinely. No special sternal retractors were used but the retractor was tilted to facilitate exposure of the hemithorax. The surgeon was positioned opposite to the lung to be operated upon. The patient was turned away from the surgeon to allow the first assistant better visualization. Hilar exposure was accomplished by a combination of traction sutures placed into the perihilar pericardium anterior to the phrenic nerve and one or two laparotomy packs placed posterior to the lung. Hilar division began with pulmonary veins, proceeded to the pulmonary artery branches, and ended with the bronchus. Early completion of the interlobar fissure facilitated the dissection of the more peripheral vascular branches. Mediastinal lymphadenectomy was performed by exposing the trachea between the extrapericardial aorta and superior vena cava. Right and left paratracheal as well as subcarninal lymph nodes were easily removed. Aortopulmonary nodes were removed by dissecting between the extrapericardial aorta and extrapleural left pulmonary artery. With the MS approach, lateral or anterior chest wall en bloc dissections were performed after the hilar structures were divided. MS patients with central tumors were easily approached intrapericardially to control the pulmonary vessels. TH patients underwent standard posterolateral, thoracotomies, entering in the fifth or sixth interspace. Ribs were not divided nor removed, but muscle-sparing incisions have been utilized more frequently in the latter years of the series. Thoracic lymphadenectomy via TH was performed in the routine manner. Fig 1. Percentage of all patients undergoing planned resection of primary lung carcinoma through a median sternotomy between 1980 and Results Eight hundred and one patients underwent 815 operations for primary lung cancer. Two patients presented with synchronous tumors and 18 patients had metachronous carcinomas resulting in second or third operations. Four hundred forty-seven MS patients and 368 TH patients were analyzed. Three hundred forty-eight of the TH patients underwent posterolateral thoracotomy. A small number of the TH group had other incisions (16 anterior thoracotomies, three posterior thoracotomies, and one thoraco-abdominal incision). Patient characteristics are shown in Table 1. There was no difference in patient age, comorbidities, or smoking history between the groups. More MS patients had been treated for COPD (31% vs 22%; p 0.027). Table 2 outlines surgical procedures. Upper lobectomies were the most common operation in the MS group. En bloc chest wall resections were more frequent in the TH group. Complete staging lymph node dissections were performed 42% of MS patients but in only 17% of TH patients ( p 0.001). There were minor differences in tumor cell type and no difference in stage between the groups. Adenocarcinoma predominated in both groups (Table 3). Mortality and complications are shown in Table 4. Operative mortality and postoperative complications were similar in both groups. Cancer stage, advanced age, male gender, and poor pulmonary function were predictive of reduced operative survival. Throughout the study period, MS patients experienced a shorter mean postoperative LOS, and more were discharged in 5 days or less than were TH patients. Long-term follow-up was 89% complete through 1998, comprising 1,339 MS and 1,463 TH patient-years, and was similar regardless of incision. Survival for stage I and stage II was similar in both groups, as noted in Figures 2 and 3. One hundred thirty-nine patients underwent a pneumonectomy (72 MS, 67 TH). Preoperative risk factors were similar in both groups. Both pneumonectomy groups had similar mortality (MS 12.5%, TH 10.4%; p NS) and complication rates. Right and left pneumonectomies were analyzed separately. There were significantly more right pneumonectomies in the MS group (45 MS, 27 TH) and a predominance of left pneumonectomies in the TH group (45 MS, 27 TH). Operative mortality for right pneumonectomy was 15.6% for MS and 11.5% for TH. For left pneumonectomy, MS mortality was 7.4% and TH mortality was 9.8%. Respiratory failure occurred in 21% of right pneumonectomies but in only 3% of left pneumonectomies ( p 0.20). The postoperative pneumonectomy LOS was 8.28 days for the MS patients and 8.19 days for TH patients (p NS). There was no difference in long-term survival for pneumonectomy regardless of surgical approach (Table 5).
3 Ann Thorac Surg ASAPH ET AL 2000;70:373 9 MEDIAN STERNOTOMY TO RESECT LUNG CANCER 375 Table 1. Preoperative Risk Factors Total cases % % Male % % NS Female % % NS Mean age NS Comorbidities Hypertension % % NS Coronary artery disease % % NS Congestive heart failure % 7 1.9% NS History of cardiac arrhythmia % % NS Peripheral vascular disease % % NS Cerebral vascular disease % % NS Chronic renal insufficiency 3 0.7% 7 1.9% NS Diabetes mellitus % % NS Chronic corticosteroid use % % NS Smoker: Never % % NS Former % % NS Current % % NS Treated for COPD % % Impaired FEV-1: Severe 5 1.1% 6 1.6% NS Moderate % % NS Mild % % NS History of other malignancies % % Previous chest surgery: Pulmonary % % Cardiac 4 0.9% % COPD chronic obstructive pulmonary disease; FEV-1 forced expiratory volume in 1 second. Five hundred eighty-one patients underwent lobectomy (331 MS, 250 TH). Preoperative risks factors and pulmonary function were similar. Postoperative complications were similar in both groups, except that reoperation for postoperative bleeding was more frequent in the MS patients (2.7% vs 0.4%). While four serious wound problems occurred in the TH groups (1.6%), there were no wound complications in the MS lobectomy patients. Operative mortality was 2.1% for MS and 2.0% for TH. Mean postoperative LOS for MS was 7.45 days compared Table 2. Surgical Procedures Surgical site Right % % Left % % Bilateral % 1 0.3% Procedure Explore/biopsy only % % NS Local excision % % NS Segmental resection 9 2.0% 9 2.4% NS Upper lobectomy % % Middle lobectomy % % NS Lower lobectomy % % Bilobectomy % % NS Pneumonectomy % % NS Bronchial sleeve resection 6 1.3% 3 0.8% NS Mediastinoscopy % % Staging mediastinal lymph node dissection % % En bloc chest wall resection 8 1.8% % 0.007
4 376 ASAPH ET AL Ann Thorac Surg MEDIAN STERNOTOMY TO RESECT LUNG CANCER 2000;70:373 9 Table 3. Pathology Histology Squamous cell % % NS Adenocarcinoma % % NS Bronchoalveolar carcinoma 5 1.1% % Large cell carcinoma % % NS Small cell carcinoma 5 1.1% 9 2.4% NS Carcinoid tumor % % NS Pulmonary sarcoma 1 0.2% 7 1.9% Staging Stage I % % NS Stage II % % NS Stage IIIA % % NS Stage IIIB % % NS Stage IV % % NS with 8.54 days for TH ( p 0.028). Lobectomy long-term survival, adjusted for stage, was the same in both groups (Table 5). Comment We analyzed 815 cases of MS and TH incisions for resection of primary lung cancer. Posterolateral thoracotomy is the gold standard incision for pulmonary resection for primary cancer. Other incisions, such as anterior thoracotomy, posterior thoracotomy, and clam shell incisions, are advocated only in selected cases [6, 7]. While these incisions give excellent exposure for surgical resection, compromise of pulmonary function, disability, and chronic pain associated with thoracotomy has been considerable [1, 7]. Additionally, adequate lymph node staging has been difficult, particularly with left-sided lesions. MS has been used for years in cardiac surgery and has not been associated with the pain and disability of TH [7]. Although cardiac surgery and lung cancer surgery patients are typically similar in terms of age, smoking histories, and comorbidities, the incidence of postoperative pulmonary complications is significantly less in those Table 4. Mortality and Complications Mortality % % NS Complications Atelectasis requiring bronchoscopy % % Pneumonia % 3 0.8% Respiratory failure % % Ventilator more than 24 hours % % NS Air leak more than 7 days % % NS Space/reexpansion % % NS Other pulmonary complications % % NS No pulmonary complications % % NS Major wound complication 4 0.9% 7 1.9% NS Pneumonectomy space infection % % NS Cardiac arrhythmia % % NS Myocardial infarction 6 1.3% 4 1.1% NS Other cardiac complications 8 1.8% 8 2.2% NS Stroke 5 1.1% 2 0.5% NS Renal failure 7 1.6% 5 1.4% NS Psychiatric % 9 2.4% NS Other complications % % NS Required reoperation % % NS Length of stay Mean days or less % % More than 10 days % % 0.134
5 Ann Thorac Surg ASAPH ET AL 2000;70:373 9 MEDIAN STERNOTOMY TO RESECT LUNG CANCER 377 patients undergoing heart surgery as compared with pulmonary operations. In the 1970s and early 1980s, surgeons began resecting bullous lesions and multiple metastatic pulmonary lesions through a sternotomy [8, 9]. As Cooper and others have shown, MS is a feasible incision to resect pulmonary tumors [1, 2, 4]. Using this approach, we previously demonstrated a shorter length of stay, less postoperative pain, and significantly less analgesic use [4]. However, the number of MS patients in each of these series was small, many common complications of pulmonary and cardiac surgery were not evaluated, there was no information regarding late pain syndromes, and follow-up was limited to the immediate postoperative period. Most significantly, there have been no data available to determine if resection through MS is as effective as TH in controlling cancer. This study was embarked upon to answer these questions and determine the place of MS in the surgical therapy of lung cancer. The cases were not randomized. Surgeon preference and anatomic concerns influenced the selection process. We consider superior sulcus tumor, left lower lobectomy, and posterior chest wall resection to be contraindications to pulmonary resection via MS. Additionally, we avoided left lung resection in the setting of previous coronary artery bypass using the left internal mammary artery because of the risk of injury to that conduit. We readily perform left and right pneumonectomies, and right-sided resection, left upper lobectomy, left superior segmentectomy, and anterior or lateral en bloc chest wall resections via MS. In patients with a previous thoracotomy, MS is an easier approach because it allows full entry into the chest away from the densest adhesions and early, safe hilar and vascular control [1]. In the present report, we did not specifically investigate late incisional pain syndromes. However, in 1987, we Fig 2. Kaplan-Meier survival curve of all patients with pathologically confirmed stage I (A and B) non-small cell carcinoma. Solid line represents sternotomy survival curve; dashed line represents thoracotomy survival curve. Represented are 281 stage I sternotomy patients and 206 stage I thoracotomy patients. Fig 3. Kaplan-Meier survival curve of all patients with pathologically confirmed stage II (A and B) non-small cell carcinoma. Solid line represents sternotomy survival curve; dashed line represents thoracotomy survival curve. Represented are 67 stage II sternotomy patients and 66 stage II thoracotomy patients. reviewed the charts of all pulmonary TH and MS patients operated upon by our group between 1980 and We found that chronic postsurgery pain syndrome was present in 12% (25 of 203) of TH patients as compared with 1% (1 of 114) of MS patients ( p 0.001). MS and TH were not different in terms of operative mortality and are similar to other large reports [10 13]. Complication rates were not statistically different between the groups. Of interest, the incidence of postoperative new atrial fibrillation was 15% in MS and 12% in TH patients. This compares with an 18% incidence in our coronary revascularization patients. As others and we have observed, MS patients experienced a shorter postoperative LOS compared with TH patients [2, 4]. More than 39% of MS patients were discharged in 5 days or less as compared with 27% of TH patients. In the later years of the study, as our incision bias tended towards MS, managed care mandated earlier discharge. However, the difference in LOS between the two groups was present in every time period during the study. The mortality and complications of pneumonectomy are similar to that reported in several large studies [10, 13] but are higher than that observed in others [14, 15]. A difference in mortality between right and left pneumonectomies has previously been noted. El-Oakley and Cameron reported an operative mortality of 37% in elderly patients undergoing right pneumonectomy compared with 6% for left pneumonectomy [16]. Nagasaki and associates observed 13.3% right pneumonectomy mortality with none for left pneumonectomy [17]. Morbidity and mortality rates for lobectomy through either incision were similar or lower than in other large reports [10, 11, 13]. Reoperations for control of bleeding were more frequent in the MS patients (2.4%), but most
6 378 ASAPH ET AL Ann Thorac Surg MEDIAN STERNOTOMY TO RESECT LUNG CANCER 2000;70:373 9 Table 5. Long-Term Survival Sternotomy Thoracotomy No. % No. % p Value 5 Year: Pneumonectomy % % NS Stage I % % NS Stage II % % NS Stage IIIA % % NS Stage IIIB 0 0.0% % NS Stage IV % 0 0.0% NS 10 Year: Pneumonectomy % % NS Stage I 2 7.2% % NS Stage II 1 8.7% % NS Stage IIIA % % NS Stage IIIB 0 0.0% % NS Stage IV 0 0.0% 0 0.0% NS 5 Year: Lobectomy % % NS Stage I % % NS Stage II % % NS Stage IIIA % % NS Stage IIIB 0 0.0% % NS Stage IV 0 0.0% 0 0.0% NS 10 Year: Lobectomy % % NS Stage I % % NS Stage II % % NS Stage IIIA 0 0.0% 1 7.6% NS Stage IIIB 0 0.0% % NS Stage IV 0 0.0% 0 0.0% NS occurred early in our series, and we attribute that to our learning curve. A major concern with MS in the treatment of lung cancer has been the fear of sternal wound infections and dehiscence [1, 3]. In our series, deep sternal wound infections and dehiscence were extraordinarily rare, particularly when compared with cardiac surgery. Lung cancer resections through a median sternotomy were associated with four of 447 (0.9%) deep sternal wound infections and no dehiscences, while there were eight (2.2%) deep wound infections and two (0.5%) dehiscences in the 368 thoracotomy patients. There were no wound complications in the 330 patients undergoing MS lobectomy, but in 249 TH lobectomies, there were three deep infections (1.2%) and one dehiscence (0.4%). By comparison, there were 44 (1.1%) deep wound infections and 16 (0.4%) dehiscences in 4,057 patients undergoing cardiac surgery through a median sternotomy at our institution between 1987 and While there is no statistical difference in wound complication rates between the two pulmonary resection groups or between cardiac and pulmonary MS operations, clearly, the wound complication risk is no higher for patients undergoing transternal pulmonary resection than it is with traditional thoracotomy or cardiac surgery. Our experience, showing an apparent difference in staging lymph node dissection between MS and TH, is a function of practice change and not real. We adopted routine thoracic lymphadenectomy in 1991 simultaneously with increase use of MS for pulmonary resection (Fig 1). However, even small or peripheral cancers can be associated with unsuspected N2/N3 lymph nodes metastases [18, 19], and skip nodal metastases are not rare [20]. Due to the technical ease, we routinely perform complete bilateral staging lymph node dissections on all patients approached through MS. Although we have not accrued sufficient 5-year survival data to confirm our impression, we believe complete lymphadenectomy will lead to up-staging and an improved survival for patients who are truly stage I. There is no compromise in cancer control using MS instead of TH. Our long-term survival results are similar to those reported in the literature [6, 21, 22]. Five-year survival for pneumonectomy and lobectomy is similar regardless of incision. Conclusions Median sternotomy provides shorter postoperative hospitalization, less postoperative pain, equivalent operative morbidity, operative mortality, and long-term survival with the potential for more complete staging when compared with thoracotomy in the surgical treatment of primary lung carcinoma.
7 Ann Thorac Surg ASAPH ET AL 2000;70:373 9 MEDIAN STERNOTOMY TO RESECT LUNG CANCER 379 References 1. Cooper JD, Nelems JM, Pearson FG. Extended indications for median sternotomy in patients requiring pulmonary resection. Ann Thoracic Surg 1978;26: Urschel HC, Razzuk MA. Median sternotomy as the standard approach for pulmonary resection. Ann Thoracic Surg 1986;41: Serry C, Bleck PC, Javid H, et al. Sternal wound complications. J Thoracic Cardiovasc Surg 1981;80: Asaph JW, Keppel JF. Midline sternotomy for the treatment of primary pulmonary neoplasms. Am J Surg 1984;147: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Thorax. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for staging cancer, 4th ed. Philadelphia: JB Lippincott Co, 1992; Shield TW. Surgical treatment of non-small cell carcinoma of the lung. In: Shield TW, ed. General thoracic surgery, 4th ed. Philadelphia: Williams & Wilkins, 1994; Heitmiller RF. Thoracic incisions. In: Baue AE, ed. Glenn s thoracic and cardiovascular surgery, 6th ed. Stamford, CT: Appleton & Lange; 1996; Lima O, Ramos L, DiBiasi P, Jadice L, Cooper JD. Median sternotomy for bilateral resection of emphysematous bullae. J Thoracic Cardiovasc Surg 1981;82: Takita H, Merrin C, Didolkar MS, Douglass HO, Edgerton F. The surgical management of multiple lung metastases. Ann Thoracic Surg 1977;24: Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: A prospective, multicenter study. Ann Thoracic Surg 1997;63: Deslauries J, Ginsberg RJ, Piantadosi S, Fournier B. Prospective assessment of 30-day morabidity for surgical resections in lung cancer. Chest (Suppl): Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thoracic Cardiovasc Surg 1999;117: Silvestri GA, Handy JR, Lackland D, Corley E, Reed CE. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998;114: Harpole DH, Liptay MJ, DeCamp MM, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thoracic Surg 1996;61: Deneffe G, Lacquet LM, Verbeken E, Vermaut G. Surgical treatment of bronchogenic carcinoma: a retrospective study of 710 thoracotomies. Ann Thoracic Surg 1988;45: El-Oakley AJ, Cameron EWJ. Pneumonectomy for bronchogenic carcinoma in the elderly. Eur J Cardiothorac Surg 1994; 8: Nagasaki F, Flehinger BJ, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 1982; 82: Asamura H, Nakayama H, Kondo H, Tsuchiya K, Shimosato Y, Naruke T. Lymph node involvement recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for videoassisted lobectomy? J Thoracic Cardiovasc Surg 1996;111: Graham ANJ, Chan KJM, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thoracic Cardiovasc Surg 1999;117: Watanabe W, Hayashi Y, Takabatake I, et al. Clinical significance of extended mediastinal lymph node dissections on the basis of clinico-pathological analysis of nodal involvement in bronchogenic carcinoma. Jpn J Thorac Surg 1994;47: Shah R, Sabanathan S, Richardson J, Mearns AJ, Goulden C. Results of surgical treatment of stage I and II lung cancer. J Cardiovasc Surg 1996;37: Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:
Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/23566
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationTreatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard
Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical
More informationMedian Sternotomy for Pneumonectomy in Patients With Pulmonary Complications of Tuberculosis
Median Sternotomy for Pneumonectomy in Patients With Pulmonary Complications of Tuberculosis Cliff P. Connery, MD, James Knoetgen III, MD, Constantine E. Anagnostopoulos, MD, and Madeline V. Svitak, BS,
More informationComplete surgical excision remains the greatest potential
ORIGINAL ARTICLE Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD,* Charles E. Eastridge, MD, Elizabeth A. Tolley,
More informationThoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014
for Locally Advanced Lung Cancer Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 Thomas A. D Amico MD Gary Hock Endowed Professor and Vice Chair of Surgery Chief Thoracic Surgery
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationPreoperative Workup for Pulmonary Resection. Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016
Preoperative Workup for Pulmonary Resection Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016 Patient Presentation 50 yo male with 70 pack year smoking history Large R hilar lung
More informationVideo-Mediastinoscopy Thoracoscopy (VATS)
Surgical techniques Video-Mediastinoscopy Thoracoscopy (VATS) Gunda Leschber Department of Thoracic Surgery ELK Berlin Chest Hospital, Berlin, Germany Teaching Hospital of Charité Universitätsmedizin Berlin
More informationLung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationReasons for conversion during VATS lobectomy: what happens with increased experience
Review Article on Thoracic Surgery Page 1 of 5 Reasons for conversion during VATS lobectomy: what happens with increased experience Dario Amore, Davide Di Natale, Roberto Scaramuzzi, Carlo Curcio Division
More informationMediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma*
Mediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma* Mediastinal Nodal Metastases in Lung Cancer Yoh Watanabe, M.D., F.C.C.P.; ]unzo Shimizu, M.D.; Makoto Tsubota, M.D.; and Takashi
More informationImpact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer
Impact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer Jakob R. Izbicki, MD, Bernward Passlick, MD, Ortrud Karg, MD, Christian Bloechle, MD, Klaus Pantel, MD, Wolfram
More informationNon-Small Cell Lung Cancer: Disease Spectrum and Management in a Tertiary Care Hospital
Non-Small Cell Lung Cancer: Disease Spectrum and Management in a Tertiary Care Hospital Muhammad Rizwan Khan,Sulaiman B. Hasan,Shahid A. Sami ( Department of Surgery, The Aga Khan University Hospital,
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationProper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer
Proper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer Özcan Birim, MD, A. Pieter Kappetein, MD, PhD, Tom Goorden, MD, Rob J. van Klaveren, MD,
More informationUniportal video-assisted thoracoscopic surgery segmentectomy
Case Report on Thoracic Surgery Page 1 of 5 Uniportal video-assisted thoracoscopic surgery segmentectomy John K. C. Tam 1,2 1 Division of Thoracic Surgery, National University Heart Centre, Singapore;
More informationHISTORY SURGERY FOR TUMORS WITH INVASION OF THE APEX 15/11/2018
30 EACTS Annual Meeting Barcelona, Spain 1-5 October 2016 SURGERY FOR TUMORS WITH INVASION OF THE APEX lung cancer of the apex of the chest involving any structure of the apical chest wall irrespective
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationStandard treatment for pulmonary metastasis of non-small
ORIGINAL ARTICLE Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer Kenichi Okubo, MD,* Toru Bando, MD,* Ryo Miyahara, MD,* Hiroaki Sakai, MD,* Tsuyoshi Shoji, MD,* Makoto Sonobe, MD,* Takuji
More informationThe roles of adjuvant chemotherapy and thoracic irradiation
Factors Predicting Patterns of Recurrence After Resection of N1 Non-Small Cell Lung Carcinoma Timothy E. Sawyer, MD, James A. Bonner, MD, Perry M. Gould, MD, Robert L. Foote, MD, Claude Deschamps, MD,
More informationEXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY
EXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY Morihito Okada, MD Noriaki Tsubota, MD Masahiro Yoshimura, MD Yoshifumi Miyamoto, MD Hidehito Matsuoka, MD, Shinsuke Satake, MD
More informationVideo-assisted thoracic surgery right upper lobe bronchial sleeve resection
Original Article on Thoracic Surgery Video-assisted thoracic surgery right upper lobe bronchial sleeve resection Qianli Ma, Deruo Liu Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationSURGICAL TECHNIQUE. Radical treatment for left upper-lobe cancer via complete VATS. Jun Liu, Fei Cui, Shu-Ben Li. Introduction
SURGICAL TECHNIQUE Radical treatment for left upper-lobe cancer via complete VATS Jun Liu, Fei Cui, Shu-Ben Li The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China ABSTRACT KEYWORDS
More informationThoracoscopic left upper lobectomy with systematic lymph nodes dissection under left pulmonary artery clamping
GCTAB Column Thoracoscopic left upper lobectomy with systematic lymph nodes dissection under left pulmonary artery clamping Yi-Nan Dong, Nan Sun, Yi Ren, Liang Zhang, Ji-Jia Li, Yong-Yu Liu Department
More informationCarcinoma of the Lung in Women
Carcinoma of the Lung in Marvin M. Kirsh, M.D., Jeanne Tashian, M.A., and Herbert Sloan, M.D. ABSTRACT The 5-year survival of 293 men and of 78 women undergoing pulmonary resection and mediastinal lymph
More informationAccomplishes fundamental surgical tenets of R0 resection with systematic nodal staging for NSCLC Equivalent survival for Stage 1A disease
Segmentectomy Made Simple Matthew J. Schuchert and Rodney J. Landreneau Department of Cardiothoracic Surgery University of Pittsburgh Medical Center Financial Disclosures none Why Consider Anatomic Segmentectomy?
More informationLung Cancer Clinical Guidelines: Surgery
Lung Cancer Clinical Guidelines: Surgery 1 Scope of guidelines All Trusts within Manchester Cancer are expected to follow this guideline. This guideline is relevant to: Adults (18 years and older) with
More informationD tion therapy, complete resection of a tumor offers
Determinants of Perioperative Morbidity and Mortality After Pneumonectomy Rakesh Wahi, MBBS, Marion J. McMurtrey, MD, Louis F. DeCaro, MD, Clifton F. Mountain, MD, Mohamed K. Ali, MD, Terry L. Smith, MS,
More informationLong-term respiratory function recovery in patients with stage I lung cancer receiving video-assisted thoracic surgery versus thoracotomy
Original Article Long-term respiratory function recovery in patients with stage I lung cancer receiving video-assisted thoracic surgery versus thoracotomy Tae Yun Park 1,2, Young Sik Park 2 1 Division
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationSignificance of Metastatic Disease
Significance of Metastatic Disease in Subaortic Lymph Nodes G. A. Patterson, M.D., D. Piazza, M.D., F. G. Pearson, M.D., T. R. J. Todd, M.D., R. J. Ginsberg, M.D., M. Goldberg, M.D., P. Waters, M.D., D.
More informationLong-Term Survival After Video-Assisted Thoracic Surgery Lobectomy for Primary Lung Cancer
Long-Term Survival After Video-Assisted Thoracic Surgery Lobectomy for Primary Lung Cancer Kazumichi Yamamoto, MD, Akihiro Ohsumi, MD, Fumitsugu Kojima, MD, Naoko Imanishi, MD, Katsunari Matsuoka, MD,
More informationCarinal resections. Leonidas Tapias, Michael Lanuti. Clinical vignette
Masters of Cardiothoracic Surgery Carinal resections Leonidas Tapias, Michael Lanuti Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA, USA Correspondence to: Michael Lanuti, MD.
More informationMediastinal Staging. Samer Kanaan, M.D.
Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor
More informationSurvival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly
and Prognosis After Pneumonectomy for Lung Cancer in the Elderly Yutaka Mizushima, MD, Hirofumi Noto, MD, Shigeki Sugiyama, MD, Yoshinori Kusajima, MD, Ryouhei Yamashita, MD, Tatsuhiko Kashii, MD, and
More informationParenchymal air leak is a frequent complication after. Pleural Tent After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect
Pleural After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect Alessandro Brunelli, MD, Majed Al Refai, MD, Marco Monteverde, MD, Alessandro Borri, MD, Michele Salati, MD, Armando
More informationPneumonectomy After Induction Rx: Is it Safe?
Pneumonectomy After Induction Rx: Is it Safe? David J. Sugarbaker, M.D. Director, Chief, Division of Thoracic Surgery The Olga Keith Weiss Chair of Surgery of Medicine at, Pneumonectomy after induction
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationTreatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer
Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer Ryoichi Nakanishi, MD, Toshihiro Osaki, MD, Kozo Nakanishi, MD, Ichiro Yoshino, MD, Takashi Yoshimatsu,
More informationPostoperative Mortality in Lung Cancer Patients
Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,
More informationTHORACIC SURGERY DIRECTORS ASSOCIATION BOOT CAMP JULY 25-28, 2013 SECTION: LUNG
THORACIC SURGERY DIRECTORS ASSOCIATION BOOT CAMP JULY 25-28, 2013 SECTION: LUNG Thoracic Faculty Richard Feins, MD (program director) University of North Carolina Jon Nesbitt, MD (course director) Vanderbilt
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationIn non small cell lung cancer, metastasis to lymph nodes, the N factor, is
Okada et al General Thoracic Surgery Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors Morihito Okada, MD, PhD Toshihiko Sakamoto, MD,
More informationVATS after induction therapy: Effective and Beneficial Tips on Strategy
VATS after induction therapy: Effective and Beneficial Tips on Strategy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J. Swanson, M.D. Professor of
More informationCASE REPORT. Introduction. Case series reports. J Thorac Dis 2012;4(S1): DOI: /j.issn s003
CASE REPORT Lost in time pulmonary metastases of renal cell carcinoma: complete surgical resection of metachronous metastases, 18 and 15 years after nephrectomy Kosmas Tsakiridis 1, Aikaterini N Visouli
More informationSurgery has been proven to be beneficial for selected patients
Thoracoscopic Lung Volume Reduction Surgery Robert J. McKenna, Jr, MD Surgery has been proven to be beneficial for selected patients with severe emphysema. Compared with medical management, lung volume
More informationTHORACIC SURGERY DIRECTORS ASSOCIATION BOOT CAMP SEPTEMBER 13-16, 2018 SECTION: LUNG
THORACIC SURGERY DIRECTORS ASSOCIATION BOOT CAMP SEPTEMBER 13-16, 2018 SECTION: LUNG Thoracic Faculty Richard Feins, MD (Program Director) University of North Carolina Jon Nesbitt, MD (Course Director)
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationLung cancer or primary malignant tumors of the mediastinum
Technique of Superior Vena Cava Resection for Lung Carcinomas David R. Jones, MD Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia School of Medicine, Charlottesville,
More informationROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER
ROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER Giulia Veronesi European Institute of Oncology Milan Lucerne, Samo 24 th - 25 th January, 2014 DIAGNOSTIC REVOLUTION FOR LUNG CANCER - Imaging
More informationShort- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer
Original Article Short- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer Takeshi Kawaguchi, MD, Takashi Tojo, MD, Keiji Kushibe, MD, Michitaka Kimura, MD, Yoko Nagata, MD, and Shigeki
More informationA Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome
World J Surg (2017) 41:780 784 DOI 10.1007/s00268-016-3777-6 ORIGINAL SCIENTIFIC REPORT A Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome Jian Li 1,2 Chengwu
More informationThoracic Surgery; An Overview
Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease
More informationP sumed to have early lung disease with a favorable
Survival After Resection of Stage I1 Non-Small Cell Lung Cancer Nael Martini, MD, Michael E. Burt, MD, PhD, Manjit S. Bains, MD, Patricia M. McCormack, MD, Valerie W. Rusch, MD, and Robert J. Ginsberg,
More informationThe accurate assessment of lymph node involvement is
ORIGINAL ARTICLE Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? Shenhai Wei, MD, PhD,*
More informationRobotic-assisted right inferior lobectomy
Robotic Thoracic Surgery Column Page 1 of 6 Robotic-assisted right inferior lobectomy Shiguang Xu, Tong Wang, Wei Xu, Xingchi Liu, Bo Li, Shumin Wang Department of Thoracic Surgery, Northern Hospital,
More informationBronchogenic Carcinoma
A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most
More informationPost-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer
Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer R. Taylor Ripley, Kei Suzuki, Kay See Tan, Manjit Bains,
More informationInduction chemotherapy followed by surgical resection
Surgical Resection for Residual N 2 Disease After Induction Chemotherapy Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Matthew A. Levin, BS, David E. Becker, MA, Roger Keresztes, MD, and Nasser
More informationSETTING Fudan University Shanghai Cancer Center. RESPONSIBLE PARTY Haiquan Chen MD.
OFFICIAL TITLE A Phase Ⅲ Study of Left Side Thoracotomy Approach (SweetProcedure) Versus Right Side Thoracotomy Plus Midline Laparotomy Approach (Ivor-Lewis Procedure) Esophagectomy in Middle or Lower
More informationCarcinoma of the Lung: A Clinical Review
Carcinoma of the Lung: A Clinical Review R. Samuel Cromartie, 111, M.D., Edward F. Parker, M.D., James E. May, M.D., John S. Metcalf, M.D., and David M. Bartles, M.S. ABSTRACT Records of 702 patients with
More informationThe tumor, node, metastasis (TNM) staging system of lung
ORIGINAL ARTICLE Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease Hao-Xian Yang, MD, PhD,* Xue Hou, MD, Peng Lin,
More informationThoracoscopic Lobectomy: Technical Aspects in Years of Progress
Thoracoscopic Lobectomy: Technical Aspects in 2015 16 Years of Progress 8 th Masters of Minimally Invasive Thoracic Surgery Orlando September 25, 2015 Thomas A. D Amico MD Gary Hock Professor of Surgery
More informationClinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis
Original Article Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis Seok Joo 1, Dong Kwan Kim 2, Hee Je Sim
More informationValue of Systematic Mediastinal Lymph Node Dissection During Pulmonary Metastasectomy
Value of Systematic Mediastinal Lymph Node Dissection During Pulmonary Metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A. Hatz, MD, Thomas Helmberger, MD, Udo Loehrs, MD, and Heinrich Fuerst,
More informationBronchial Carcinoma and the Lymphatic Sump: The Importance of Bronchoscopic Findings
Bronchial Carcinoma and the Lymphatic Sump: The Importance of Bronchoscopic Findings Gordon F. Murray, M.D., Ormond C. Mendes, M.D., and Benson R. Wilcox, M.D. ABSTRACT The lymphatic sump of Borrie is
More informationUniportal video-assisted thoracoscopic right upper posterior segmentectomy with systematic mediastinal lymphadenectomy
Surgical Technique Uniportal video-assisted thoracoscopic right upper posterior segmentectomy with systematic mediastinal lymphadenectomy Guofei Zhang 1, Zhijun Wu 2, Yimin Wu 1, Gang Shen 1, Ying Chai
More informationMEDIASTINAL STAGING surgical pro
MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical
More informationM expected to arise in 1.6% to 3.0% of all patients. Multiple Primary Lung Carcinomas: Prognosis and Treatment
Multiple Primary Lung Carcinomas: Prognosis and Treatment Todd K. Rosengart, MD, Nael Martini, MD, Pierre Ghosn, MD, and Michael Burt, MD, PhD Thoracic Service, Department of Surgery, Memorial-Sloan Kettering
More informationVideo-assisted thoracoscopic (VATS) lobectomy has
Robot-Assisted Lobectomy for Early-Stage Lung Cancer: Report of 100 Consecutive Cases Farid Gharagozloo, MD, Marc Margolis, MD, Barbara Tempesta, MS, CRNP, Eric Strother, LSA, and Farzad Najam, MD Washington
More informationUniportal video-assisted thoracic surgery for complicated pulmonary resections
Review Article on Thoracic Surgery Uniportal video-assisted thoracic surgery for complicated pulmonary resections Ding-Pei Han, Jie Xiang, Run-Sen Jin, Yan-Xia Hu, He-Cheng Li Jiaotong University School
More informationThe Role of Radiation Therapy
The Role of Radiation Therapy and Surgery in the Treatment of Bronchogenic Carcinoma R Adams Cowley, M.D., Morris J. Wizenberg, M.D., and Eugene J. Linberg, M.D. A study of the combined use of preoperative
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationPreoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant, MD, Sonia Blandin, MD, Isabelle Arnaud, MD, Pascal
More informationMinimally Invasive Esophagectomy
Minimally Invasive Esophagectomy M A R K B E R R Y, M D A S S O C I AT E P R O F E S S O R D E PA R T M E N T OF C A R D I O T H O R A C I C S U R G E R Y S TA N F O R D U N I V E R S I T Y S E P T E M
More informationParenchyma-sparing lung resections are a potential therapeutic
Lung Segmentectomy for Patients with Peripheral T1 Lesions Bryan A. Whitson, MD, Rafael S. Andrade, MD, and Michael A. Maddaus, MD Parenchyma-sparing lung resections are a potential therapeutic option
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationSurgery for early stage NSCLC
1-3 March 2017, Manchester, UK Surgery for early stage NSCLC Dominique H. Grunenwald, MD, PhD Professor Emeritus in Thoracic and Cardiovascular surgery Pierre & Marie Curie University. Paris. France what
More informationUniportal complete video-assisted thoracoscopic surgery lobectomy with partial pulmonary arterioplasty for lung cancer with calcified lymph node
Surgical Technique Uniportal complete video-assisted thoracoscopic surgery lobectomy with partial pulmonary arterioplasty for lung cancer with calcified lymph node Guang-Suo Wang, Jian Wang, Zhan-Peng
More informationThe Learning Curve for Minimally Invasive Esophagectomy
The Learning Curve for Minimally Invasive Esophagectomy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J Swanson, M.D. Professor of Surgery Harvard
More informationL cancer-related deaths in Japan. The number of patients
Extended Resection of the Left Atrium, Great Vessels, or Both for Lung Cancer Ryosuke Tsuchiya, MD, Hisao Asamura, MD, Haruhiko Kondo, MD, Tomoyuki Goya, MD, and Tsuguo Naruke, MD Division of Thoracic
More informationSubsequent Pulmonary Resection for Bronchogenic Carcinoma After Pneumonectomy
ORIGINAL ARTICLES: GENERAL THORACIC Subsequent Pulmonary Resection for Bronchogenic Carcinoma After Pneumonectomy Jessica S. Donington, MD, Daniel L. Miller, MD, Charles C. Rowland, BS, Claude Deschamps,
More informationStandardized definitions and policies of minimally invasive thymoma resection
Perspective Standardized definitions and policies of minimally invasive thymoma resection Alper Toker 1,2 1 Department of Thoracic Surgery, Istanbul Medical School, Istanbul University, Istanbul, Turkey;
More information141 Ann Thorac Surg , Aug Copyright by The Society of Thoracic Surgeons
Completion Pneumonectomy: Indications, Complications, and Results Eilis M. McGovern, M.B.B.Ch., Victor F. Trastek, M.D., Peter C. Pairolero, M.D., and W. Spencer Payne, M.D. ABSTRACT From 958 through 985,
More informationand Strength of Recommendations
ASTRO with ASCO Qualifying Statements in Bold Italics s patients with T1-2, N0 non-small cell lung cancer who are medically operable? 1A: Patients with stage I NSCLC should be evaluated by a thoracic surgeon,
More informationOriginal papers. Concomitant Cardiac Surgery and Pulmonary Resection
Original papers Acta Chir Belg, 2009, 109, 306-311 Concomitant Cardiac Surgery and Pulmonary Resection K. Cathenis* ( 1 ), **, R. Hamerlijnck*, F. Vermassen**, G. Van Nooten***, F. Muysoms* *Department
More informationClinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer
Clinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer Reference: NHS England B10X03/01 Information Reader Box (IRB) to be inserted on inside front cover for
More informationRoutine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF)
Routine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF) Abstract The results of 25 cases underwent a pedicled pericardial flap coverage for the bronchial
More informationHistory of Surgery for Lung Cancer
Welcome to Master Class for Oncologists Session 1: 7:30 AM - 8:15 AM San Francisco, CA October 23, 2009 Innovations in The Surgical Treatment of Lung Cancer Speaker: Scott J. Swanson, MD 2 Presenter Disclosure
More information